单节段腰椎退行病内镜下经椎间孔腰椎体间融合

Endoscopic transforaminal lumbar interbody fusion for single-segment lumbar degenerative diseases

[目的]探讨经皮全内镜下经椎间孔椎体间融合术治疗单节段腰椎疾病的疗效。[方法]2015年6月—2019年5月,对24例单节段腰椎疾病患者采用经皮全内镜下经椎间孔椎体间融合术治疗。评价临床与影像资料。[结果]24例患者均顺利完成手术,无严重并发症。随时间推移,腰痛VAS评分、腿痛VAS评分、ODI评分均显著减少(P<0.05)。影像方面,术后3个月及末次随访时,椎间隙高度较术前显著增加(P<0.05),L2S1前凸角略有增加,但差异无统计学意义(P>0.05)。所有患者均获得椎间融合,无椎间融合器移位、螺钉及连接棒移位断裂等发生。[结论]采用经皮全内镜下经椎间孔椎体间融合术治疗单节段腰椎疾病疗效满意。

[Objective]To explore the clinical outcomes of percutaneous full-endoscopic transforaminal lumbar interbody fusion for single-segment lumbar disease.[Method]From June 2015 to May 2019,24 patients with single-segment lumbar disease were treated with percutaneous full-endoscopic transforaminal lumbar interbody fusion.The clinical and radiographic documents were evaluated.[Results]All patients had operation performed smoothly without serious complications.The VAS scores for back pain and leg pain,as well as ODI score significantly decreased over time(P<0.05).Radiographically,the intervertebral space significantly increased(P<0.05),whereas the lumbar lordotic angle slight increased without statistical significance postoperatively compared with those preoperatively(P>0.05).All pa⁃tients achieved intervertebral fusion without implant loosening or breaking until the latest follow-up.[Conclusion]This percutaneous fullendoscopic transforaminal lumbar interbody fusion does achieve satisfactory clinical outcomes for single-segment lumbar degenerative dis⁃eases.